GlassScriptPhysician profile
Michael J Gillman
NPI 1275536633
$5,643.92
in general payments reported to CMS, 2019-2025
39 companies · $405 in 2025
The $405 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,329 · 2020: $667 · 2021: $819 · 2022: $564 · 2023: $1,467 · 2024: $394 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,140 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,140.20 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,627.69 | 2019-2025 | Beta-Bsm, Oxford, Affixus |
| Conformis, INC. | $1,036.99 | 2019 | |
| Abbott Laboratories | $864.03 | 2020-2023 | Proclaim |
| Stryker Corporation | $383.37 | 2020-2025 | Mako, Pangea |
| Smith+Nephew, INC. | $322.66 | 2021-2025 | Pico, Pico 14, Pico 7 |
| Merz Pharmaceuticals, LLC | $185.15 | 2021-2022 | |
| Biotissue Holdings INC. | $138.57 | 2021-2024 | |
| Aesculap, INC. | $88.39 | 2024 | Aesculap |
| Pacira Pharmaceuticals Incorporated | $74.48 | 2022-2024 | Zilretta, Iovera, Exparel |
| Ermi LLC | $69.08 | 2019-2020 | |
| Merz North America, INC. | $59.66 | 2019-2020 | |
| Djo, LLC | $59.07 | 2023 | Donjoy, Aircast |
| Bioventus LLC | $50.99 | 2020-2024 | Durolane |
| Redhill Biopharma INC. | $50.43 | 2021-2022 | |
| Omnilife Science, INC | $49.75 | 2024 | Various Products |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gillman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.